Cleveland Clinic
 
A National Dialogue on Biomedical Conflicts of Interest  
InterContinental Hotel & MBNA Conference Center
Cleveland, Ohio - September 20, 2006

InterContinental HotelPost proceedings video is now available to purchase online at www.postproceedings.com.

Medical schools, hospitals and biomedical research institutions are increasing their partnerships with industry with the purposes of bringing discoveries forward more quickly to benefit patients and potentially providing a revenue stream to supplement research support. In some cases, these partnerships have appeared unethical and created public suspicion that an individual's or company's, not the patient's, interest is really being served. These conflicts of interest are the subject of vigorous debate. Should these conflicts be avoided completely or managed? Can they be managed? If yes, how can they best be managed? Who should set the standards? "A National Dialogue on Biomedical Conflicts of Interest and Innovation Management" brings prominent thinkers to a common podium for a full day of exchanging views on these and related topics. Outstanding speakers, moderators and panelists, recognized leaders in academic biomedical research, industry, government, medical research publishing, bioethics, and professional medical organizations, will participate in interactive discussions with a target audience of decision makers from all of these communities.

Topics:

  • Research, Innovation and Safety: Doing the Right Thing
  • Guiding Principles: Where are We Headed?
  • Applications in the Real World: Defining Boundaries and Managing Innovation
  • Conflicts, Compliance and Enforcement: Government Priorities and Initiatives
  • Guidelines and Performance: Creating a Culture of Ethics

Confirmed Speakers:

  • Richard Thornburgh, Former U.S. Attorney General, Governor of Pennsylvania and Director of a publicly traded pharmaceutical company
  • Roy Vagelos, MD, Former CEO, Merck
  • Nina Totenberg, National Public Radio, Legal Affairs Correspondent
  • Darrell Kirch, MD, Incoming President, AAMC
  • Bernard Schwetz, DVM, PhD, Director, Office of Human Research Protections
  • Thomas Stossel, MD, Professor of Medicine, Harvard Medical School
  • Ed Soule, PhD, CPA, Associate Professor, Georgetown University
  • Jeffrey Kahn, PhD, Director, Center for Bioethics, University of Minnesota
  • Philip A. Pizzo, MD, Dean, Stanford University School of Medicine
  • James Sheehan, U.S. Assistant Attorney General, Department of Justice
  • Jeffrey M. Drazen, MD, Editor in Chief, New England Journal of Medicine
  • Gail H. Cassell, PhD, D.Sc. (hon) Vice President, Scientific Affairs and Distinguished Lilly Research Scholar for Infectious Diseases, Eli Lilly and Company
  • Paul LaViolette, COO Boston Scientific: Chairman, Special Committee on Codes of Ethics, AdvaMed
  • Norka Ruiz-Bravo, PhD, Deputy Director for Extramural Research, National Institutes of Health
  • Edward Miller, MD, Dean & CEO, Johns Hopkins University School of Medicine

Who Should Attend:
Decision makers from biomedical research institutions, clinical centers, industry and government.

A unique opportunity to listen to and discuss key issues regarding innovation in contemporary biomedical research and medicine.

With Support From:

 

Cleveland Clinic | 9500 Euclid Ave. | Cleveland, Ohio 44195
Jamie Belkin Events, Summit Coordinator
Phone: 216-932-3448 | Fax: 216-932-0444